Clinical Trial Detail

NCT ID NCT03743662
Title Nivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

glioblastoma multiforme

Therapies

Nivolumab

Bevacizumab

Age Groups: adult senior

Additional content available in CKB BOOST